As of Jul 28
| +0.17 / +4.33%|
The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +1,460.98% increase from the last price of 4.10.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.